Further analysis of LSD2 expression across all molecular subtypes of breast cancer showed that LSD2 mRNA level is significantly higher in basal-like tumors as compared to other breast cancer subtypes or normal tissues (Figure 1D) (TCGA data downloaded from GSE62944). This evidence concerns the gene KDM1B and breast carcinoma.